136 related articles for article (PubMed ID: 11705445)
1. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.
Berry C; McMurray J
Am J Med; 2001 Nov; 111(7):587. PubMed ID: 11705445
[No Abstract] [Full Text] [Related]
2. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
Schepkens H; Vanholder R; Billiouw JM; Lameire N
Am J Med; 2001 Apr; 110(6):438-41. PubMed ID: 11331054
[TBL] [Abstract][Full Text] [Related]
3. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
Dutka M; Dzielski T; Wojciechowska J; Heller L; Trybus M
Pol Merkur Lekarski; 1999 Aug; 7(38):69-70. PubMed ID: 10522422
[TBL] [Abstract][Full Text] [Related]
4. Syncope caused by hyperkalemia during use of a combined therapy with the angiotensin-converting enzyme inhibitor and spironolactone.
Erden I; Yalcin S; Ozhan H
Kardiol Pol; 2010 Sep; 68(9):1043-5; discussion 1046. PubMed ID: 20859899
[TBL] [Abstract][Full Text] [Related]
5. Elderly heart failure patients with drug-induced serious hyperkalemia.
Vanpee D; Swine CH
Aging (Milano); 2000 Aug; 12(4):315-9. PubMed ID: 11073352
[TBL] [Abstract][Full Text] [Related]
6. [The 10-minute consultation. Accidental finding: hyperkalemia. Caution with analgesics and bananas].
Lenz T
MMW Fortschr Med; 2005 Jan; 147(4):59-60. PubMed ID: 15745346
[No Abstract] [Full Text] [Related]
7. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
[No Abstract] [Full Text] [Related]
8. Life-threatening hyperkalemia during a combined therapy with the angiotensin receptor blocker candesartan and spironolactone.
Fujii H; Nakahama H; Yoshihara F; Nakamura S; Inenaga T; Kawano Y
Kobe J Med Sci; 2005; 51(1-2):1-6. PubMed ID: 16199929
[TBL] [Abstract][Full Text] [Related]
9. Drug safety in patients with heart failure.
Juurlink DN; Hansten PD
Arch Intern Med; 2005 Jan; 165(1):118. PubMed ID: 15642888
[No Abstract] [Full Text] [Related]
10. Hyperkalemia in ambulant postcardiac surgery patients during combined therapy with angiotensin-converting enzyme inhibitor, spironolactone, and diet rich in potassium: A report of two cases and review of literature.
Dixit A; Majumdar G; Tewari P
Ann Card Anaesth; 2019; 22(2):162-168. PubMed ID: 30971598
[TBL] [Abstract][Full Text] [Related]
11. Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
Jarman PR; Keheley AM; Mather HM
Diabet Med; 1997 Sep; 14(9):808. PubMed ID: 9300234
[No Abstract] [Full Text] [Related]
12. [An elderly man with known heart failure admitted with cardiogenic shock].
Hovland A; Fagerheim AK; Hardersen R; Nielsen EW
Tidsskr Nor Laegeforen; 2010 Jul; 130(13):1352-4. PubMed ID: 20596117
[TBL] [Abstract][Full Text] [Related]
13. [Late drug-induced hyperkalemia in a patient with congestive heart failure].
Konopa J; Bułło B; Rutkowski B
Przegl Lek; 2005; 62(7):732-3. PubMed ID: 16463712
[TBL] [Abstract][Full Text] [Related]
14. Study warns of danger of combining spironolactone and ACE inhibitors in heart patients.
Gottlieb S
BMJ; 2004 Aug; 329(7463):420. PubMed ID: 15321896
[No Abstract] [Full Text] [Related]
15. Diabetes may be independent risk factor for hyperkalaemia.
Jarman PR; Mather HM
BMJ; 2003 Oct; 327(7418):812. PubMed ID: 14525902
[No Abstract] [Full Text] [Related]
16. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
Fuster D; Frey FJ; Ferrari P
Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
[TBL] [Abstract][Full Text] [Related]
17. Interaction of spironolactone with ACE inhibitors or angiotensin receptor blockers: analysis of 44 cases.
Wrenger E; Müller R; Moesenthin M; Welte T; Frölich JC; Neumann KH
BMJ; 2003 Jul; 327(7407):147-9. PubMed ID: 12869459
[No Abstract] [Full Text] [Related]
18. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
Dinsdale C; Wani M; Steward J; O'Mahony MS
Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
[No Abstract] [Full Text] [Related]
19. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
[TBL] [Abstract][Full Text] [Related]
20. Spironolactone in patients with heart failure.
Vanpee D; Swine C
N Engl J Med; 2000 Jan; 342(2):133; author reply 133-4. PubMed ID: 10636753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
